HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nu Skin formulates peptides

This article was originally published in The Rose Sheet

Executive Summary

Personal care products formulated with a new proprietary technology will debut in the third and fourth quarters of 2004 under partnership with German pharmaceutical firm Cosmix, direct-seller says March 13. Cosmix, which specializes in peptide and protein ingredient technologies, will help Nu Skin create a pipeline of "scientifically-advanced" products, Provo, Utah marketer states. Deal is expected to increase demand for Nu Skin's products and to "drive greater distributor activity over the next several years," company adds. Technology, which is in the first phase of a four-stage development process, also could be incorporated into existing products. Pentapeptide technology currently is used in Nu Skin's Tru Face Line Corrector anti-aging product...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel